173 related articles for article (PubMed ID: 32105365)
1. Affinity Maturation of Macrocyclic Peptide Modulators of Lys48-Linked Diubiquitin by a Twofold Strategy.
Huang Y; Nawatha M; Livneh I; Rogers JM; Sun H; Singh SK; Ciechanover A; Brik A; Suga H
Chemistry; 2020 Jun; 26(36):8022-8027. PubMed ID: 32105365
[TBL] [Abstract][Full Text] [Related]
2. The RaPID Platform for the Discovery of Pseudo-Natural Macrocyclic Peptides.
Goto Y; Suga H
Acc Chem Res; 2021 Sep; 54(18):3604-3617. PubMed ID: 34505781
[TBL] [Abstract][Full Text] [Related]
3. De novo macrocyclic peptides that specifically modulate Lys48-linked ubiquitin chains.
Nawatha M; Rogers JM; Bonn SM; Livneh I; Lemma B; Mali SM; Vamisetti GB; Sun H; Bercovich B; Huang Y; Ciechanover A; Fushman D; Suga H; Brik A
Nat Chem; 2019 Jul; 11(7):644-652. PubMed ID: 31182821
[TBL] [Abstract][Full Text] [Related]
4. In vitro selection of multiple libraries created by genetic code reprogramming to discover macrocyclic peptides that antagonize VEGFR2 activity in living cells.
Kawakami T; Ishizawa T; Fujino T; Reid PC; Suga H; Murakami H
ACS Chem Biol; 2013; 8(6):1205-14. PubMed ID: 23517428
[TBL] [Abstract][Full Text] [Related]
5. An Extended Conformation for K48 Ubiquitin Chains Revealed by the hRpn2:Rpn13:K48-Diubiquitin Structure.
Lu X; Ebelle DL; Matsuo H; Walters KJ
Structure; 2020 May; 28(5):495-506.e3. PubMed ID: 32160516
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Selection of Thioether-Closed Macrocyclic Peptide Ligands by Means of the RaPID System.
Katoh T; Goto Y; Suga H
Methods Mol Biol; 2022; 2371():247-259. PubMed ID: 34596852
[TBL] [Abstract][Full Text] [Related]
7. Display Selection of Exotic Macrocyclic Peptides Expressed under a Radically Reprogrammed 23 Amino Acid Genetic Code.
Passioura T; Liu W; Dunkelmann D; Higuchi T; Suga H
J Am Chem Soc; 2018 Sep; 140(37):11551-11555. PubMed ID: 30157372
[TBL] [Abstract][Full Text] [Related]
8. Natural product-like macrocyclic N-methyl-peptide inhibitors against a ubiquitin ligase uncovered from a ribosome-expressed de novo library.
Yamagishi Y; Shoji I; Miyagawa S; Kawakami T; Katoh T; Goto Y; Suga H
Chem Biol; 2011 Dec; 18(12):1562-70. PubMed ID: 22195558
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Selection of Macrocyclic α/β
Wakabayashi R; Kawai M; Katoh T; Suga H
J Am Chem Soc; 2022 Oct; 144(40):18504-18510. PubMed ID: 36173923
[TBL] [Abstract][Full Text] [Related]
10. Ribosomal Synthesis of Macrocyclic Peptides with β
Adaligil E; Song A; Hallenbeck KK; Cunningham CN; Fairbrother WJ
ACS Chem Biol; 2021 Jun; 16(6):1011-1018. PubMed ID: 34008946
[TBL] [Abstract][Full Text] [Related]
11. Discovery of De Novo Macrocyclic Peptides by Messenger RNA Display.
Peacock H; Suga H
Trends Pharmacol Sci; 2021 May; 42(5):385-397. PubMed ID: 33771353
[TBL] [Abstract][Full Text] [Related]
12. Asparaginyl Endopeptidase-Mediated Peptide Cyclization for Phage Display.
Wan XC; Zhang YN; Zhang H; Chen Y; Cui ZH; Zhu WJ; Fang GM
Org Lett; 2024 Apr; 26(13):2601-2605. PubMed ID: 38529932
[TBL] [Abstract][Full Text] [Related]
13. Recognition of Poly-Ubiquitins by the Proteasome through Protein Refolding Guided by Electrostatic and Hydrophobic Interactions.
Zhang Y; Vuković L; Rudack T; Han W; Schulten K
J Phys Chem B; 2016 Aug; 120(33):8137-46. PubMed ID: 27012670
[TBL] [Abstract][Full Text] [Related]
14. Membrane Permeability in a Large Macrocyclic Peptide Driven by a Saddle-Shaped Conformation.
Faris JH; Adaligil E; Popovych N; Ono S; Takahashi M; Nguyen H; Plise E; Taechalertpaisarn J; Lee HW; Koehler MFT; Cunningham CN; Lokey RS
J Am Chem Soc; 2024 Feb; 146(7):4582-4591. PubMed ID: 38330910
[TBL] [Abstract][Full Text] [Related]
15. Combining Chemical Protein Synthesis and Random Nonstandard Peptides Integrated Discovery for Modulating Biological Processes.
Saha A; Suga H; Brik A
Acc Chem Res; 2023 Jul; 56(14):1953-1965. PubMed ID: 37312234
[TBL] [Abstract][Full Text] [Related]
16. A High Affinity hRpn2-Derived Peptide That Displaces Human Rpn13 from Proteasome in 293T Cells.
Lu X; Liu F; Durham SE; Tarasov SG; Walters KJ
PLoS One; 2015; 10(10):e0140518. PubMed ID: 26466095
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of selective recognition of Lys48-linked polyubiquitin by macrocyclic peptide inhibitors of proteasomal degradation.
Lemma B; Zhang D; Vamisetti GB; Wentz BG; Suga H; Brik A; Lubkowski J; Fushman D
Nat Commun; 2023 Nov; 14(1):7212. PubMed ID: 37938554
[TBL] [Abstract][Full Text] [Related]
18. The hydrophobic effect contributes to polyubiquitin chain recognition.
Beal RE; Toscano-Cantaffa D; Young P; Rechsteiner M; Pickart CM
Biochemistry; 1998 Mar; 37(9):2925-34. PubMed ID: 9485444
[TBL] [Abstract][Full Text] [Related]
19. Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 Reveal Distinct Binding Mechanisms between Substrate Receptors and Shuttle Factors of the Proteasome.
Chen X; Randles L; Shi K; Tarasov SG; Aihara H; Walters KJ
Structure; 2016 Aug; 24(8):1257-1270. PubMed ID: 27396824
[TBL] [Abstract][Full Text] [Related]
20. Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein-Protein Interactions.
Krüger DM; Glas A; Bier D; Pospiech N; Wallraven K; Dietrich L; Ottmann C; Koch O; Hennig S; Grossmann TN
J Med Chem; 2017 Nov; 60(21):8982-8988. PubMed ID: 29028171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
